Most people with hemophilia A do not meet physical activity recommendations, according to a new study, which also found that there was no apparent link between...
Findings published in Molecular Therapy examined the clinical immunogenicity outcomes of valoctocogene roxaparvovec, an adeno-associated virus serotype 5 (AAV5)–vectored gene therapy, in adults with severe hemophilia...